Recently, there has been important emphasis in pharmaceutical analysis on the stability of drug formulations and the development of appropriate stability-indicating studies. In this regard, a comprehensive stability-illustrating RP-HPLC approach has been established and validated for the assay of denaverine hydrochloride (DEN) and benzyl alcohol (BNZ) in Sensiblex® Injectable Solution.Different stress conditions were applied to both components, following the guidelines of the International Conference on Harmonization (ICH). Using the isocratic elution technique, DEN, BNZ, and their degradation products were effectively isolated and quantified on an Inertsil C8 column at room temperature. The mobile phase consisted of acetonitrile: water: orthophosphoric acid (80:20:0.1, by volume), and the flow speed was maintained at 0.8 mL/min. Detection was performed at 220 nm using a diode array detector, with concentration ranges of 10.00–30.00 and 5.00–15.00 μg/mL for DEN and BNZ, respectively. The total analysis time was less than five minutes, establishing this novel chromatographic method as a priority for routine quality control analysis of both drugs. The inclusion of acetonitrile was necessary for achieving adequate resolution. The environmental impact was evaluated using three approaches: Green Analytical Procedure Index (GAPI), Analytical Eco-Scale, and Analytical GREEnness metric (AGREE). Additionally, White Analytical Chemistry (WAC) was employed to evaluate the quality (R), ecological impact (G), and economic viability (B) of the developed approach.Additionally, the newly presented Blue Applicability Grade Index (BAGI) metric was also assessed. The final Eco-scale score of 85 and the AGREE score of 0.65 indicate the environmentally friendly nature of the new chromatographic method. The BAGI final score was 82.5, while the overall score of the WAC tool was 91.8, highlighting the method's practicality and utility. DEN exhibits the highest degradation (24%) in acidic conditions, whereas BNZ is particularly susceptible to oxidative degradation, with a degradation percentage of 35%. New four degradation products were formed, and the two investigated compounds were efficiently separated and analyzed in their presence. Further identification of degradation products for DEN and BNZ is strongly recommended, employing a mass spectrophotometric detector. Notably, the novel method is accurate, reliable, economical, and time-efficient. In conclusion, it can be effectively employed for routine quality control and stability assessment of DEN and BNZ in both their pure form and pharmaceutical formulations.
Read full abstract